dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
Published 1 year ago • 151 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:04
dreamm-3: belantamab mafodotin vs pom/dex for r/r myeloma
-
2:15
results of dreamm-4: safety and efficacy of belantamab mafodotin with pembrolizumab in r/r myeloma
-
4:32
real-world efficacy and safety of belantamab mafodotin in patients with triple class-exposed myeloma
-
10:43
phase 3, open-label, randomized trial comparing belamaf to pd in rrmm: dreamm-3 study
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
4:19
blinatumomab to achieve remission and consolidation with haplosct for pediatric all
-
7:48
glofitamab, a cd20/cd3 bispecific antibody, in the treatment of r/r dlbcl
-
4:58
livderm / dr. susan weinkle - cosmetic injection demonstration - 3d animation
-
5:38
dreamm-6: safety and tolerability of belantamab mafodotin in combination with bortezomib/dex in rrmm
-
3:00
results of a phase i study of belantamab mafodotin in combination with krd for treating myeloma
-
2:05
belantamab mafodotin combined with lenalidomide and dexamethasone in r/r mm: insights from dreamm-6
-
15:46
dreamm-8: belantamab mafodotin pomalidomide and dex shows improved outcomes in rr multiple myeloma
-
5:15
dreamm-2 & dreamm-5: belantamab mafodotin for myeloma
-
1:38
the safety and efficacy of belantamab mafodotin in r/r multiple myeloma in the real world
-
0:58
belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
-
2:16
insights into the safety and efficacy of belantamab mafodotin in systemic al amyloidosis
-
1:36
dreamm-2: belantamab mafodotin for r/r myeloma
-
8:05
dreamm-2: belantamab mafodotin for r/r mm
-
3:25
belantamab mafodotin and its place in myeloma treatment